Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01010984
What this trial is testing

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

Who this might be right for
Stage IV Melanoma
Robert C. Martin 20
Early research (Phase 1)Active Not RecruitingNCT06961786
What this trial is testing

TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 With Lymphocyte-depleting Chemotherapy and TILs in the Treatment of Melanoma

Who this might be right for
Metastatic Melanoma
TILT Biotherapeutics Ltd. 9
Early research (Phase 1)Study completedNCT04217473
What this trial is testing

TNFalpha and Interleukin 2 Coding Oncolytic Adenovirus TILT-123 During TIL Treatment of Advanced Melanoma

Who this might be right for
Metastatic Melanoma
TILT Biotherapeutics Ltd. 17
Testing effectiveness (Phase 2)Study completedNCT03123783
What this trial is testing

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

Who this might be right for
CancerNon Small Cell Lung Cancer MetastaticMetastatic Melanoma+2 more
Apexigen America, Inc. 140
Testing effectiveness (Phase 2)UnknownNCT00153569
What this trial is testing

Multiepitope Peptide Vaccination in Melanoma

Who this might be right for
Metastatic Melanoma
Charite University, Berlin, Germany 25
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT02052193
What this trial is testing

Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study

Who this might be right for
Metastatic Melanoma (Carrying BRAF V600 Mutation)
University Hospital Tuebingen 8
Testing effectiveness (Phase 2)Study completedNCT00006233
What this trial is testing

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07215182
What this trial is testing

[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Who this might be right for
Malignant Melanoma Stage IV
Barbara Malene Fischer 20
Testing effectiveness (Phase 2)Study completedNCT00058279
What this trial is testing

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00044356
What this trial is testing

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaMalignant Melanoma+1 more
Vical 133
Testing effectiveness (Phase 2)Study completedNCT00019994
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01055522
What this trial is testing

Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Philogen S.p.A. 102
Testing effectiveness (Phase 2)UnknownNCT01217398
What this trial is testing

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
Institut Curie 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07740941
What this trial is testing

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage Stage IIIBMelanoma Stage M1+1 more
UNC Lineberger Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)UnknownNCT04633902
What this trial is testing

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

Who this might be right for
Metastatic Melanoma
California Pacific Medical Center Research Institute 41
Early research (Phase 1)Study completedNCT00002754
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer
Duke University 6
Very early researchStudy completedNCT03655756
What this trial is testing

PDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IV
TuHURA Biosciences, Inc. 7
Not applicableLooking for participantsNCT04693377
What this trial is testing

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the Bone+15 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT04521075
What this trial is testing

A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC

Who this might be right for
Melanoma Stage IVUnresectable MelanomaNSCLC Stage IV
Ella Therapeutics Ltd 42
Next Page